FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

The Supreme Court granted certiorari to review whether a generic drugmaker that fully carves out a patented use from its ...

Survey findings and why they matter for Arcutis Biotherapeutics stock Arcutis Biotherapeutics (ARQT) has put fresh attention on chronic skin disease care by releasing its Skin Insights survey, ...

Follow these tips to stay safe.

Dr. Alfred Croteau, an acute care surgeon with HealthCare, said that the next week in Connecticut will bring dangerous cold ...

SHRC initiates legal action against pharma firm for drug mix-up at Thiruvananthapuram's Regional Cancer Centre, ensuring accountability.

A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...

The costs of at least 350 drugs in the U.S. are expected to rise in 2026, according to a new analysis, despite many of the drugmakers pledging to offer more favorable prices under new Trump ...

Julián Arístides González was up before dawn, grinding the coffee beans he’d grown from seedlings in his front yard. His wife, Leslie Portillo, was already dressed, and his daughter, Giulliana, needed ...

Just days after an upbeat R&D event, Neurocrine Biosciences has found itself having to report a phase 3 failure. The company’s Ingrezza (valbenazine), approved to treat certain uncontrolled movement ...

The White House announced Friday that nine additional pharmaceutical companies have agreed to follow President Trump’s “most favored nation” (MFN) drug pricing policy, with some of the companies ...

Daniel Payne reports on how the health industry and Washington influence and impact each other. He joined STAT in 2025 after covering health care at POLITICO. You can reach Daniel on Signal at danielp ...